Beryl Drugs Approves Increased Related Party Transaction Limit with Aminova Infusions
Beryl Drugs Ltd · Others (Uncategorized) · 29 Sept 2026, 5:22 pm
Beryl Drugs Approves Increased Related Party Transaction Limit with Aminova Infusions At its 33rd AGM on 29th Sep'26, Beryl Drugs Limited secured shareholder approval to increase the aggregate limit for material related party transactions with M/s Aminova Infusions Pvt. Ltd. from ₹5.00 crore to ₹8.00 crore. The revised ₹8.00 crore limit serves as the overall ceiling across the originally approved two-year tenure granted at the EGM on 11th May'26. All other terms, conditions, and transaction parameters remain unchanged, conducted in the ordinary course of business at arm's length.
Original exchange filing (PDF)
More announcements from Beryl Drugs Ltd
- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.09.2026 · 14 Nov 2026
- OUTCOME OF BOARD MEETING · 14 Nov 2026
- Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve to consider and approve unaudited .... · 14 Nov 2026
- NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026 · 08 Oct 2026
- VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026 · 01 Oct 2026
- PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING · 29 Sept 2026
- OUTCOME OF 33RD ANNUAL GENERAL MEETING · 29 Sept 2026
- ANNUAL REPORT 2025-2026 · 04 Sept 2026
